DUS4L suppresses invasion and metastasis in LUAD via modulation of PI3K/AKT and ERK/MAPK signaling through GRB2
Our results establish the functional role of DUS4L in driving the progression and metastasis of LUAD, implicating its potential as a candidate therapeutic target for LUAD.
Authors
- Huirong Huang
- Kerong Zhai (ORCID: https://orcid.org/0000-0002-6017-5668)
- Yuqi Meng
- Shilin Wei (ORCID: https://orcid.org/0000-0002-0596-2888)
- Xing Gao (ORCID: https://orcid.org/0000-0001-8893-2416)
- Xuan Li (ORCID: https://orcid.org/0009-0008-3016-2648)
- Bin Li (ORCID: https://orcid.org/0000-0002-4080-3268)
- Zheng Li
- Haiming Feng
- Zhenqing Li (ORCID: https://orcid.org/0000-0002-0637-4295)
- Pei-Lin Zhao
Institutions
- Lanzhou University Second Hospital (CN)
- Lanzhou University (CN)
Publication Details
- Journal
- International Immunopharmacology
- Published
- 2024-08-30
- DOI
- https://doi.org/10.1016/j.intimp.2024.113043
- Citations
- 8
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 1.87
Funders
- Lanzhou University